Key Data by Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HealthCare

 

CropScience

 

Covestro

 

Reconciliation

 

 

 

 

 

Pharmaceuticals

 

Consumer Health

 

CropScience

 

Covestro

 

All Other Segments

 

Corporate Center and Consolidation

 

Group

 

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

3rd Quarter 2014

3rd Quarter 2015

 

 

€ million

€ million

 

€ million

€ million

 

€ million

€ million

 

€ million

€ million

 

€ million

€ million

 

€ million

€ million

 

€ million

€ million

Net sales (external)

 

3,039

3,482

 

1,701

2,169

 

1,929

2,113

 

3,036

3,009

 

261

262

 

1

1

 

9,967

11,036

Change

 

+7.8%

+14.6%

 

+1.3%

+27.5%

 

+12.7%

+9.5%

 

+4.8%

−0.9%

 

−10.3%

+0.4%

 

 

+6.0%

+10.7%

Currency-adjusted change

 

+10.3%

+11.7%

 

+3.8%

+24.0%

 

+14.8%

+2.2%

 

+5.1%

−7.7%

 

−10.0%

+1.1%

 

 

+7.7%

+5.8%

Intersegment sales

 

29

8

 

3

4

 

9

6

 

14

18

 

567

575

 

(622)

(611)

 

Net sales (total)

 

3,068

3,490

 

1,704

2,173

 

1,938

2,119

 

3,050

3,027

 

828

837

 

(621)

(610)

 

9,967

11,036

EBIT

 

699

859

 

363

360

 

157

180

 

184

217

 

47

2

 

(104)

(53)

 

1,346

1,565

EBIT before special items

 

699

866

 

309

399

 

157

184

 

186

304

 

54

58

 

(104)

(42)

 

1,301

1,769

EBITDA before special items

 

960

1,139

 

408

538

 

278

309

 

334

472

 

99

105

 

(102)

(40)

 

1,977

2,523

Gross cash flow1

 

666

781

 

244

336

 

214

206

 

261

310

 

151

(166)

 

(70)

(40)

 

1,466

1,427

Net cash flow1

 

808

894

 

260

379

 

598

677

 

274

326

 

164

(114)

 

(323)

144

 

1,781

2,306

Depreciation, amortization and impairments

 

261

273

 

99

141

 

121

126

 

149

171

 

45

47

 

2

2

 

677

760

 

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

 

First Nine Months 2014

First Nine Months 2015

2014 figures restated

1

For definition see “Financial Position of the Bayer Group.”

2

Full-time equivalents

Net sales (external)

 

8,781

10,174

 

4,943

6,889

 

7,299

7,928

 

8,703

9,208

 

815

803

 

6

3

 

30,547

35,005

Change

 

+6.9%

+15.9%

 

−1.5%

+39.4%

 

+6.3%

+8.6%

 

+1.8%

+5.8%

 

−5.9%

−1.5%

 

 

+3.5%

+14.6%

Currency-adjusted change

 

+12.1%

+10.0%

 

+3.9%

+32.6%

 

+12.2%

+1.2%

 

+4.2%

−3.2%

 

−5.2%

−1.2%

 

 

+7.9%

+7.5%

Intersegment sales

 

72

26

 

7

4

 

40

25

 

42

45

 

1,639

1,705

 

(1,800)

(1,805)

 

Net sales (total)

 

8,853

10,200

 

4,950

6,893

 

7,339

7,953

 

8,745

9,253

 

2,454

2,508

 

(1,794)

(1,802)

 

30,547

35,005

EBIT

 

1,996

2,256

 

924

1,017

 

1,615

1,625

 

512

714

 

106

45

 

(307)

(315)

 

4,846

5,342

EBIT before special items

 

1,992

2,361

 

883

1,248

 

1,615

1,704

 

533

902

 

126

123

 

(307)

(293)

 

4,842

6,045

EBITDA before special items

 

2,760

3,204

 

1,188

1,704

 

1,991

2,082

 

970

1,402

 

250

259

 

(303)

(288)

 

6,856

8,363

Gross cash flow1

 

1,902

2,191

 

779

1,110

 

1,453

1,448

 

760

981

 

472

102

 

(217)

(221)

 

5,149

5,611

Net cash flow1

 

1,547

2,079

 

626

1,148

 

847

596

 

363

849

 

364

(57)

 

(253)

318

 

3,494

4,933

Depreciation, amortization and impairments

 

772

847

 

305

479

 

376

384

 

441

525

 

124

136

 

4

5

 

2,022

2,376

Number of employees (as of Sep. 30)2

 

38,808

40,045

 

16,533

18,655

 

22,490

23,673

 

14,147

15,698

 

20,105

19,086

 

748

709

 

112,831

117,866